Massive Breakthrough As Cancer Drug Caused All Patients' Tumors To Disappear

Dostarlimab, a new drug tested for colorectal cancer has left doctors speechless after it showed a 100% success rate in clinical trials.

The drug is produced with laboratory-produced molecules which act as substitute antibodies in the human body. The researchers were left speechless after all 18 participants were considered in remission one year after the drug trial.

Getty Images

Following the shocking results, doctors conducted endoscopies, physical tests, PET scans, and MRI scans but they were unable to find any traces of cancer in their bodies.

Dr Luis A. Diaz Jr. of New York's Memorial Sloan Kettering Cancer Center said this was 'the first time this has happened in the history of cancer'.

Credit: Alexey Kotelnikov / Alamy Stock Photo

Dr. Diaz along with his team of researchers published a paper on their findings in the New England Journal of Medicine, describing their phenomenal results.

Their amazing findings have created waves in the world of medicine, with Dr Alan P. Venook telling the New York Times that complete remission in every single patient is 'unheard of'.

Dr Venook is a colorectal cancer specialist at the University of California and even though he was not part of the research but he has hailed it as the world-first.

Alamy stock photo

Dr Venook stated that it is impressive as there were no significant complications observed in any of the patients during the trial.

The 18 patients who had been part of this treatment previously faced haunting treatments, that involved chemotherapy, radiation and invasive surgery that could result in bowel, urinary, and even sexual dysfunction.

Credit: Alexey Kotelnikov / Alamy Stock Photo

These patients went into the trial expecting to face more serious side effects of the treatment, but instead, no further treatment was needed.

Memorial Sloan Kettering Cancer Center and a co-author of the paper, oncologist Dr. Andrea Cercek, described the moment patients found out they were cancer-free.

"There were a lot of happy tears," she told the New York Times.

According to Cancer Australia, colorectal cancer, also known as bowel cancer affects 100,000 Australians each year.

This new drug is the latest to make waves in the world of medicine.

Back in May, another team of doctors in the US unveiled their own groundbreaking research in which the scientists injected the first-ever human patient with a new genetically modified cancer-killing virus.

According to medical reports, the drug- Vaxinia - has already proven to be successful in animal testing, so scientists and medical researchers have high hopes for what the results will be for humans.

So far it has been observed that the oncolytic virus shrinks colon, lung, breast, ovarian and pancreatic cancer tumours in animal trials.